Clinical experience and preliminary research have suggested that topical opioids are an effective local analgesic.
Mechanism of action
The insight that opioids exert a local analgesic effect is based on several observations:
- opioid receptors have been found on peripheral nerves and inflamed tissue
and its metabolites are largely undetectable systemically when applied topically to skin ulcers (suggesting the analgesic effect is local)
- peripheral opioid injections for local analgesia, such as intra-articular morphine
after knee surgery, have been found to be effective in several trials. Of note, animal studies suggest that opioids can accelerate wound healing by up-regulating nitric-oxide synthase. The relevance of this for humans is unknown and there is no consensus regarding whether or not topical opioids benefit or impede wound healing in humans.
Several small case series have shown rapid relief using topical opioids in patients with pain due to skin infiltration of tumor, skin ulcers of malignant and non-malignant origin, severe oral mucositis, knee arthritis, and tenesmoid pain. Most studies have evaluated morphine
, although diamorphine
have also shown efficacy.
Three randomized, double-blinded, placebo-controlled studies totaling 34 patients assessed the efficacy of topical opioids for treating painful ulcers (mostly sacral pressure ulcers). These studies found significantly lower pain scores in patients treated with topical opioids compared with placebo. In general, pain decreased 2-3 points on a 0-10 pain scale.
Another blinded, controlled trial of 18 patients showed topical morphine
to be no more effective than placebo. This study’s outcome however was complete pain relief, not just significant analgesic response as in the other studies. Itching and burning are common side effects reported by both patients receiving morphine
and placebo vehicle-gel. No systemic side effects were reported.
A dose-response relationship has been reported for patients with painful oral mucositis; rinses with 2% morphine solution showed better pain relief than those with 1%. One non-blinded, randomized study of 26 patients that compared morphine
mouthwash (an oral rinse of 2 % morphine
solution) with “magic” mouthwash (a mixture of equal parts lidocaine
, and magnesium aluminum hydroxide
) found significantly decreased duration and intensity of pain in the morphine
Topical opioid gels and mouthwashes are not available commercially and need to be prepared by a compounding pharmacist.
- Gel: most studies used a mixture of 10 mg of morphine sulfate
injection (10 mg/ml) in 8 gm of gel. Patients are instructed to cover their wound with the gel (usually using 5-10 ml) and then loosely dress it with gauze. Duration of analgesia varies widely; preparations usually need to be applied one to three times per day.
- Mouthwash: the morphine
mouthwash which has been studied is an oral rinse of 15 ml of 2 % morphine solution (2000 mg morphine clorhydrate
diluted in 1000 ml of water). It can be taken every 3 hours as needed. Patients should be instructed to hold the mouthwash in their mouth for 2 minutes then spit out. They should be counseled carefully to not swallow the mouthwash to avoid systemic effects from the morphine.
Adapted from Jacobsen J. Palliative Care Network of Wisconsin. Fast facts and concepts #185. Topical opioids for pain. Internet. Accessed on January 25, 2016.